VERALOX THERAPEUTICS Trademark

Trademark Overview

On Friday, November 16, 2018, a trademark application was filed for VERALOX THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the VERALOX THERAPEUTICS trademark a serial number of 88197022. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 1, 2022. This trademark is owned by Veralox Therapeutics Inc.. The VERALOX THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, chemical and small molecule and biological preparations for use in treatment of blood disorders and diabetes; pharmaceutical and biological formulations for treatment of blood disorders and diabetes
veralox therapeutics

General Information

Serial Number88197022
Word MarkVERALOX THERAPEUTICS
Filing DateFriday, November 16, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 1, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 30, 2019

Trademark Statements

Goods and ServicesPharmaceutical products, namely, chemical and small molecule and biological preparations for use in treatment of blood disorders and diabetes; pharmaceutical and biological formulations for treatment of blood disorders and diabetes
Disclaimer with Predetermined Text"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 4, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVeralox Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFrederick, MD 21704
Party NameVeralox Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFrederick, MD 21704

Trademark Events

Event DateEvent Description
Monday, August 1, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 1, 2022ABANDONMENT - NO USE STATEMENT FILED
Saturday, October 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 1, 2021SOU EXTENSION 5 GRANTED
Thursday, September 23, 2021SOU EXTENSION 5 FILED
Thursday, September 23, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, April 28, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 26, 2021SOU EXTENSION 4 GRANTED
Monday, April 26, 2021SOU EXTENSION 4 FILED
Monday, April 26, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, September 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 4, 2020SOU EXTENSION 3 GRANTED
Friday, September 4, 2020SOU EXTENSION 3 FILED
Friday, September 4, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, May 6, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 4, 2020SOU EXTENSION 2 GRANTED
Monday, May 4, 2020SOU EXTENSION 2 FILED
Monday, May 4, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, November 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 15, 2019SOU EXTENSION 1 GRANTED
Friday, November 15, 2019SOU EXTENSION 1 FILED
Friday, November 15, 2019SOU TEAS EXTENSION RECEIVED
Wednesday, November 6, 2019CORRECTED NOA E-MAILED
Tuesday, November 5, 2019DIVISIONAL PROCESSING COMPLETE
Wednesday, October 23, 2019DIVISIONAL REQUEST RECEIVED
Tuesday, November 5, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 23, 2019TEAS REQUEST TO DIVIDE RECEIVED
Monday, October 14, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 14, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 25, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 30, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 30, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 10, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 25, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 25, 2019ASSIGNED TO LIE
Tuesday, March 5, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 5, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, March 5, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 5, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, March 5, 2019EXAMINERS AMENDMENT -WRITTEN
Wednesday, February 27, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 27, 2019NON-FINAL ACTION E-MAILED
Wednesday, February 27, 2019NON-FINAL ACTION WRITTEN
Wednesday, February 20, 2019ASSIGNED TO EXAMINER
Tuesday, December 4, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 20, 2018NEW APPLICATION ENTERED

Related Keywords

therapeutics veralox treatment blood disorders diabetes pharmaceutical biological products formulations namely chemical